PREMARKET ALERT: Spectrum Pharmaceuticals (SPPI)

Posted in General 
July 21st, 2009

Spectrum Pharmaceuticals Inc. (Nasdaq: SPPI) shares are up more than 5 percent to $6.20 in early premarket trading of fewer than 2,000 shares. The FDA has given a fast-track designation for the company’s investigation of its apaziquone candidate for the treatment of non-muscle invasive bladder cancer.  — Mike Tarsala

Comments are closed